查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1318077

H1N1 疫苗市场：依给药途径、品牌类型、通路划分 - 2023-2030 年全球预测

H1N1 Vaccines Market by Route of Administration, Type of Brand, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球 H1N1 疫苗市场将大幅成长，达到 99.3494 亿美元，年复合成长率为 35.49%，预计到 2030 年将达到惊人的 833.963 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球H1N1疫苗市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.甲型H1N1流感疫苗全球市场规模及预测为何？

2.在预测期内，COVID-19 对全球 H1N1 疫苗市场的阻碍因素和影响为何？

3.预测期内全球H1N1疫苗市场需要投资哪些产品/细分市场/应用/领域？

4.全球H1N1疫苗市场的竞争策略为何？

5.全球甲型H1N1流感疫苗市场的技术趋势与法律规范为何？

6.全球H1N1疫苗市场主要厂商的市占率是多少？

7. 哪些型态和策略性措施被认为适合甲型H1N1疫苗进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 流行性 H1N1 流感感染疾病发生率增加
      • 孕妇和儿童灭活流感疫苗的需求
      • 过渡到基于细胞的製造
    • 抑制因素
      • 製造过程耗时且昂贵
    • 机会
      • 公私部门合作伙伴关係实现具有成本效益的供应
      • 疫苗技术的进步
    • 任务
      • H1N1 疫苗的常见副作用
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章H1N1 疫苗市场：依给药途径分类

  • 皮内疫苗
  • 肌内疫苗
  • 鼻内疫苗

第7章H1N1 疫苗市场（依品牌类型）

  • 阿格里帕尔
  • 菲亚里克斯
  • 流感
  • 流感
  • 纳索瓦茨
  • 八喜握把

第8章H1N1 疫苗市场：依通路划分

  • 医院药房
  • 网路药房
  • 零售药房

第9章美洲H1N1疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区H1N1疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲H1N1疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-437E9896A50C

The Global H1N1 Vaccines Market is forecasted to grow significantly, with a projected USD 9,934.94 million in 2023 at a CAGR of 35.49% and expected to reach a staggering USD 83,396.30 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global H1N1 Vaccines Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global H1N1 Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Route of Administration, market is studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines. The Intranasal Vaccines is projected to witness significant market share during forecast period.

Based on Type of Brand, market is studied across Agripal, Fiuarix, Influgen, Influvac, Nasovac, and Vaxigrip. The Nasovac is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Hospital Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global H1N1 Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global H1N1 Vaccines Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global H1N1 Vaccines Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global H1N1 Vaccines Market?

4. What is the competitive strategic window for opportunities in the Global H1N1 Vaccines Market?

5. What are the technology trends and regulatory frameworks in the Global H1N1 Vaccines Market?

6. What is the market share of the leading vendors in the Global H1N1 Vaccines Market?

7. What modes and strategic moves are considered suitable for entering the Global H1N1 Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. H1N1 Vaccines Market, by Route of Administration, 2022 vs 2030
  • 4.3. H1N1 Vaccines Market, by Type of Brand, 2022 vs 2030
  • 4.4. H1N1 Vaccines Market, by Distribution Channel, 2022 vs 2030
  • 4.5. H1N1 Vaccines Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of epidemic H1N1 infection
      • 5.1.1.2. Demand for inactivated influenza vaccine in pregnant women and children
      • 5.1.1.3. Shift towards cell-based manufacturing
    • 5.1.2. Restraints
      • 5.1.2.1. Time consuming manufacturing process and high cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Public-private partnerships for cost effective supply
      • 5.1.3.2. Technological advancements in the vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Common side effects associated with H1N1 vaccines
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. H1N1 Vaccines Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intradermal Vaccines
  • 6.3. Intramuscular Vaccines
  • 6.4. Intranasal Vaccines

7. H1N1 Vaccines Market, by Type of Brand

  • 7.1. Introduction
  • 7.2. Agripal
  • 7.3. Fiuarix
  • 7.4. Influgen
  • 7.5. Influvac
  • 7.6. Nasovac
  • 7.7. Vaxigrip

8. H1N1 Vaccines Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas H1N1 Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific H1N1 Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa H1N1 Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. H1N1 VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. H1N1 VACCINES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 5. H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2022 VS 2030 (%)
  • FIGURE 6. H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. H1N1 VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. H1N1 VACCINES MARKET DYNAMICS
  • FIGURE 9. H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. H1N1 VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 5. H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 9. H1N1 VACCINES MARKET SIZE, BY AGRIPAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. H1N1 VACCINES MARKET SIZE, BY FIUARIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. H1N1 VACCINES MARKET SIZE, BY INFLUGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. H1N1 VACCINES MARKET SIZE, BY INFLUVAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. H1N1 VACCINES MARKET SIZE, BY NASOVAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. H1N1 VACCINES MARKET SIZE, BY VAXIGRIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY TYPE OF BRAND, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. H1N1 VACCINES MARKET LICENSE & PRICING